Onconova Therapeutics, Inc.
Amendment
CIK: 0001130598·Biotechnology·DELAWARE·Filed: Jul 26, 2012
Total Offering
$30,000,000
Amount Sold
$26,444,316
Investors
41
First Sale
Apr 27, 2012
Offering Details
- Type
- Equity, Option to Acquire, Other: Convertible Promissory Notes, convertible into Series I Preferred Stock, under certain circumstances.
- Exemptions
- Rule 506
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Ramesh Kumar, Ph.D. | |
| E. Premkumar Reddy, Ph.D. | |
| Alan R. Williamson | |
| K. Ravindra | |
| Viren Mehta | |
| Pankaj Patel | |
| Michael Hoffman | |
| Henry S. Bienen |
Company
SEC Filing
0000943663-12-000124
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free